0001474064-12-000007.txt : 20120119 0001474064-12-000007.hdr.sgml : 20120119 20120119160902 ACCESSION NUMBER: 0001474064-12-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120117 FILED AS OF DATE: 20120119 DATE AS OF CHANGE: 20120119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Selisker Rachel R CENTRAL INDEX KEY: 0001313793 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 12534776 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0304 4 2012-01-17 0000890465 NPS PHARMACEUTICALS INC NPSP 0001313793 Selisker Rachel R 550 HILLS DRIVE BEDMINSTER NJ 07921 1 0 0 0 Deferred Stock Units 2012-01-17 4 A 0 2278 0 A Common Stock 2278 144074 D Each Deferred Stock Unit represents a right to receive one share of NPS Common Stock. Deferred Stock Units awarded under the NPS Pharmaceuticals, Inc. 2007 Nonemployee Directors' Compensation Program will be settled in NPS Common Stock upon (1) separation from service on the Board, (2) death, (3) disability, or (4) sale of substantially all the assets of the Company. /s/ Edward Stratemeier as Attorney-in-Fact 2012-01-19